Literature DB >> 31586896

Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.

Li-Rong Wu1, Xiu-Ming Zhang2, Xiao-Dong Xie2, Yue Lu1, Jian-Feng Wu1, Xia He3.   

Abstract

OBJECTIVES: This study aimed to validate the 8th edition of American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) TNM staging system for nasopharyngeal carcinoma (NPC) in non-endemic region.
MATERIALS AND METHODS: We recruited 607 patients with histology-proven, previously untreated, non-metastatic NPC treated by intensity-modulated radiotherapy (IMRT) at our center. Harrell's concordance index (c-index) and Akaike information criterion (AIC) were applied to compare the prognostic discrimination between the 7th and 8th edition staging system.
RESULTS: For T category, the local recurrence-free survival (LRFS) Kaplan-Meier curves of T1, T2 and T3 were well separated in the 8th edition; however, LRFS did not significantly differ between T3 and T4 (P = 0.166). Moreover, the 7th edition achieved higher c-index (0.702 [95% CI, 0.618-0.787] vs. 0.685 [95% CI, 0.604-0.767]) and lower AIC (766.1 vs. 770.8) than 8th edition for LRFS. With regard to N category, the 8th edition achieved higher c-index (0.796 [95% CI, 0.749-0.843] vs. 0.751 [95% CI, 0.696-0.805]) and lower AIC (1439.4 vs. 1471.9) for distant metastasis-free survival. In terms of overall stage, the 8th edition also had higher c-index (0.798 [95% CI, 0.753-0.844] vs. 0.721 [95% CI, 0.672-0.770]) and lower AIC (1963.9 vs. 2007.2) compared with the 7th edition for overall survival. Furthermore, interval validation by bootstrapping the sample randomly for ~100-1000 times also validated above findings.
CONCLUSION: The 8th edition of AJCC/UICC TNM staging system achieved significantly better prognostic discrimination than the 7th edition with regard to N category and overall stage but not T category.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AJCC/UICC; Nasopharyngeal carcinoma; Prognosis; Radiotherapy; TNM staging system

Year:  2019        PMID: 31586896     DOI: 10.1016/j.oraloncology.2019.09.029

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance.

Authors:  Jingbo Wang; Xiaodong Huang; Shiran Sun; Kai Wang; Yuan Qu; Xuesong Chen; Runye Wu; Ye Zhang; Qingfeng Liu; Jianghu Zhang; Jingwei Luo; Jianping Xiao; Li Gao; Guozhen Xu; Chen Hu; Ye-Xiong Li; Junlin Yi
Journal:  Cancer Med       Date:  2021-05-06       Impact factor: 4.452

2.  Development and validation of a prognostic nomogram for the pre-treatment prediction of early metachronous metastasis in endemic nasopharyngeal carcinoma: a big-data intelligence platform-based analysis.

Authors:  Lu-Lu Zhang; Fei Xu; Wen-Ting He; Meng-Yao Huang; Di Song; Yi-Yang Li; Qi-Ling Deng; Yong-Shi Huang; Ting Wang; Jian-Yong Shao
Journal:  Ther Adv Med Oncol       Date:  2020-12-21       Impact factor: 8.168

3.  Nogo-B promotes invasion and metastasis of nasopharyngeal carcinoma via RhoA-SRF-MRTFA pathway.

Authors:  Jingyi Wang; Qian Zhong; Hua Zhang; Shangxin Liu; Shibing Li; Tianliang Xia; Zhiwen Xiao; Renhui Chen; Yuchu Ye; Faya Liang; Ping Han; Xiaoming Huang
Journal:  Cell Death Dis       Date:  2022-01-24       Impact factor: 8.469

4.  A Nomogram Based on Circulating CD4+ T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.

Authors:  De-Song Shen; Chang Yan; Kai-Hua Chen; Ling Li; Song Qu; Xiao-Dong Zhu
Journal:  J Inflamm Res       Date:  2021-12-09

5.  Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma.

Authors:  De-Song Shen; Chang Yan; Yu Liang; Kai-Hua Chen; Xiao-Dong Zhu
Journal:  Cancer Manag Res       Date:  2021-10-27       Impact factor: 3.989

6.  Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up.

Authors:  Lei Wang; Zheng Wu; Wanqin Cheng; Dehuan Xie; Feifei Lin; Liangping Xia; Yong Su
Journal:  Radiat Oncol       Date:  2021-11-06       Impact factor: 3.481

Review 7.  Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options.

Authors:  Rina Jiromaru; Takashi Nakagawa; Ryuji Yasumatsu
Journal:  Cancer Manag Res       Date:  2022-09-12       Impact factor: 3.602

8.  Detailed analysis of recovery process of cranial nerve palsy after IMRT-based comprehensive treatment in nasopharyngeal carcinoma.

Authors:  Jian Zang; Yan Li; Shanquan Luo; Jianhua Wang; Bingxin Hou; Min Yao; Lina Zhao; Mei Shi
Journal:  Radiat Oncol       Date:  2021-06-27       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.